Saturday, February 13, 2016

Researchers identify 'neurostatin' that may reduce the risk of Alzheimer's disease

Researchers have identified a drug that targets the first step in the toxic chain reaction leading to the death of brain cells, suggesting that treatments could be developed to protect against Alzheimer’s disease, in a similar way to how statins are able to reduce the risk of developing heart disease.

from Dementia Big http://ift.tt/1Lll49y via alcoholic dementia


http://ift.tt/1TZa5d2

No comments:

Post a Comment